USPTO serial 79201619
Serial No. 79201619
Reviewed by CopyMark Law Group
Reg. 5537623Status 706Registered
- Filing date
- Status date
- Registration date
- Aug 14, 2018
- Examiner
- FENNESSY, EDWARD JOHN
- Law office
- TMEG LAW OFFICE 101
What this means
This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.
Need help with Serial No. 79201619?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
EUROIMMUN Medizinische Labordiagnostika AG
DE
Other trademarks owned by EUROIMMUN Medizinische Labordiagnostika AG
EUROIMMUN Medizinische Labordiagnostika AG
DE
Other trademarks owned by EUROIMMUN Medizinische Labordiagnostika AG
EUROIMMUN Medizinische Labordiagnostika AG
Lübeck, DE
Other trademarks owned by EUROIMMUN Medizinische Labordiagnostika AG
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Eric Myers
Eric Myers GRüNEBERG AND MYERS PLLC1775 TYSONS BLVD.5TH FLOORTYSONS, VA 22102United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical preparations for commercial, scientific and photographic purposes, namely, Biological tissue cultures, other than for medical or veterinary purposes; [ Biological tissue cultures, other than for medical or veterinary purposes, on glass slides; ] Biological tissue, namely, mammalian tissue and cells for use in scientific and medical research; Biological tissue, namely, blood [ , stem cells, umbilical cords and placentas ] for scientific and medical research use; [ Biological tissue, namely, a set of matched frozen and fixed human biological specimens derived from the division of one original specimen for use in scientific and medical research; ] Chemical and biological reagents, namely, Reagents for use in scientific apparatus for chemical or biological analysis; Laboratory chemicals, namely, an antibody reagent used for the detection of antigens in cell and tissue analysis for in vitro diagnostic use other than for medical or veterinary purposes; Monoclonal antibodies for in vitro scientific or research use; Protein for industrial use; Protein in raw material form for scientific and medical research; Protein arrays and nucleotide arrays for scientific and medical research; Proteins for use in manufacture; Proteins for the food industry; diagnostic reagents, namely, virus for in vitro scientific or research use; diagnostic reagents, namely, flavivirus for in vitro scientific or research use; Nucleic acid for laboratory use; Nucleic acid sequences and chemical reagents for other than medical and veterinary purposes; Biological preparation for use in cell cultures other than for medical or veterinary use; Cells for scientific and research use | ACTIVE | — |
| 005 | [ Diagnostic preparations for pharmaceutical, medical and veterinary purposes, namely, Ovulation test kits; Drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids; ] Diagnostic test kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; Diagnostic test kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, neurological diseases, autoimmune diseases, infectious diseases, allergies; Biochips, namely, [ glass or ] plastic carriers with protein, tissue, cells or antigen used for medical diagnostics; Blots, namely, carriers coated with diagnostic reagents for medical use; Line blots, namely, carriers coated with diagnostic reagents for medical use; Dot blots, namely, carriers coated with diagnostic reagents for medical use; Microtiter plates, namely, carriers coated with diagnostic reagents for medical use; Medical diagnostic test strips for use in the field of neurological diseases, autoimmune diseases, infectious diseases, allergies; Medical diagnostic test strips for blood, urine and liquor analysis | ACTIVE | — |
| 009 | Scientific, surveying, photographic, optical, measuring and control apparatus and instruments, namely, Fluorescence microscopes; [ Cameras; ] Scanners for diagnostics, namely, flatbed scanners, drum scanners and hand-held scanners for reading images from medical devices, blots, line blots, dot blots, microtiter plates, and microscopy slides for laboratory and research use; [ Photometers; Mass spectrometers; Bar code readers; ] Diagnostic apparatus for the profiling of antibodies, antigens and nucleotides for laboratory or research use; [ polymerase chain reaction thermocyclers for nucleotide amplification for laboratory and research purposes; immunoassay staining devices; immunoassay staining instruments; Analytical apparatus, namely, an automated slide stainer for use in medical laboratories; ] Laboratory equipment and supplies, namely, incubators and incubator trays for laboratory or research purposes; Constant temperature incubators for laboratory use; [ Constant humidity incubators for laboratory use; ] Laboratory equipment and supplies, namely, washing trays for laboratory or research purposes; [ Incubators for bacteria cultures; ] Chemiluminescence detectors for use in protein and nucleotide research for laboratory or research purposes; [ fluorescence detector for crime scene investigations; ] fluorescence detector for diagnosis of neurological diseases, infectious diseases, autoimmune diseases, allergies and cancer, for laboratory or research purposes; [ furniture especially made for laboratories; calculators; computer hardware for data processing; Computer hardware for high-speed processing and storage of data; ] Computer [ hardware and ] software, for use with medical patient monitoring equipment, for receiving, processing, transmitting and displaying data; Computers; computer software for running a fluorescence [ or nuclear ] medicine diagnostic imaging apparatus and evaluating diagnostic assays; CDs featuring [ movies, films, audiobooks, music, diagnostic data and ] device manuals | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by EUROIMMUN Medizinische Labordiagnostika AG
- Other trademarks owned by EUROIMMUN Medizinische Labordiagnostika AG
- Other trademarks owned by EUROIMMUN Medizinische Labordiagnostika AG
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 12, 2026 | INNP | PARTIAL INVALIDATION PROCESSED BY THE IB | — |
| Oct 14, 2026 | XXSS | GENERIC MADRID TRANSACTION SENT TO IB | — |
| Oct 14, 2026 | XXCR | GENERIC MADRID TRANSACTION CREATED | — |
| Sep 24, 2026 | RNWL | INTERNATIONAL REGISTRATION RENEWED | — |
| Feb 9, 2026 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Jun 9, 2025 | NA71 | NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED | — |
| Jun 9, 2025 | 71AG | REGISTERED-SEC.71 ACCEPTED | — |
| Jun 2, 2025 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Feb 14, 2025 | ES71 | TEAS SECTION 71 RECEIVED | — |
| Aug 14, 2023 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Feb 1, 2019 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Dec 1, 2018 | XXSS | GENERIC MADRID TRANSACTION SENT TO IB | — |
| Dec 1, 2018 | XXCR | GENERIC MADRID TRANSACTION CREATED | — |
| Nov 14, 2018 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Aug 14, 2018 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| May 30, 2018 | CORR | CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED | — |
| May 29, 2018 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 29, 2018 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 25, 2018 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| May 9, 2018 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| May 9, 2018 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| May 9, 2018 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Apr 25, 2018 | EXPT | EXPARTE APPEAL TERMINATED | — |
| Apr 25, 2018 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 25, 2018 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Apr 25, 2018 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Apr 25, 2018 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Apr 25, 2018 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Apr 19, 2018 | CRCV | CORRECTION TRANSACTION RECEIVED FROM IB | — |
| Mar 23, 2018 | EXPI | EX PARTE APPEAL-INSTITUTED | — |
| Mar 23, 2018 | JURT | JURISDICTION RESTORED TO EXAMINING ATTORNEY | — |
| Mar 23, 2018 | EXAF | EXPARTE APPEAL RECEIVED AT TTAB | — |
| Feb 27, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 27, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 27, 2018 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Feb 23, 2018 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 23, 2018 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Sep 25, 2017 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Sep 25, 2017 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Sep 25, 2017 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Aug 30, 2017 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 30, 2017 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 29, 2017 | ALIE | ASSIGNED TO LIE | — |
| Aug 11, 2017 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 25, 2017 | RFNT | REFUSAL PROCESSED BY IB | — |
| Feb 22, 2017 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Feb 22, 2017 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Feb 21, 2017 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Feb 19, 2017 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Feb 18, 2017 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 17, 2017 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 17, 2017 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 16, 2017 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |